Menu Philippe 4

What Happened

• Philippe Menu, Chief Medical Officer of SOPHiA GENETICS SA, sold 608 shares in an open-market transaction on April 20, 2026. The filing reports a weighted average price of $5.20 per share for total proceeds of approximately $3,162. The sale was made to satisfy tax withholding obligations arising from restricted stock units that vested on April 18, 2026.

Key Details

• Transaction date: 2026-04-20; Form 4 filed: 2026-04-21 (within the 2-business-day reporting window).
• Price: weighted average $5.20; trades ranged between $5.10 and $5.29 (per footnote).
• Shares sold: 608; total proceeds ≈ $3,162.
• Post-transaction holdings: not specified in the provided filing excerpt.
• Footnotes: Sale was effected under a pre-established Rule 10b5-1(c) trading plan and was non-discretionary, executed to cover tax withholding on RSU vesting. The filer can provide a breakdown of shares sold at each price within the reported range upon written request.

Context

• This was an administrative, tax-withholding sale tied to RSU vesting and executed under a 10b5-1 plan, a routine event that typically does not indicate a change in insider sentiment.